Novo CEO pressed by Senate to chop costs of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the business would take into consideration new talks with insurers regarding the record costs of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Financial commitment in https://kethek.com/